Axa S.A. Glycomimetics Inc Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.55 - $3.49 $1,129 - $1,546
443 Added 0.03%
1,587,741 $4.76 Million
Q4 2023

Jul 16, 2024
SELL
$1.13 - $2.54 $500 - $1,125
-443 Reduced 0.03%
1,587,298 $3.75 Million
Q4 2023

Feb 14, 2024
SELL
$1.13 - $2.54 $43,391 - $97,536
-38,400 Reduced 2.36%
1,587,298 $3.75 Million
Q3 2023

Nov 14, 2023
SELL
$1.29 - $1.73 $7,496 - $10,053
-5,811 Reduced 0.36%
1,625,698 $2.44 Million
Q2 2023

Aug 14, 2023
BUY
$1.21 - $2.08 $27,162 - $46,691
22,448 Added 1.4%
1,631,509 $2.84 Million
Q1 2023

May 15, 2023
BUY
$1.25 - $4.05 $2.01 Million - $6.52 Million
1,609,061 New
1,609,061 $2.03 Million
Q2 2020

Aug 14, 2020
SELL
$2.06 - $3.76 $63,036 - $115,056
-30,600 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.83 - $5.41 $1.67 Million - $4.95 Million
-914,646 Reduced 96.76%
30,600 $70,000
Q4 2019

Feb 18, 2020
BUY
$4.03 - $6.5 $130,479 - $210,450
32,377 Added 3.55%
945,246 $5 Million
Q3 2019

Nov 14, 2019
SELL
$2.8 - $12.85 $49,509 - $227,213
-17,682 Reduced 1.9%
912,869 $3.93 Million
Q2 2019

Aug 13, 2019
BUY
$10.6 - $13.12 $57,314 - $70,939
5,407 Added 0.58%
930,551 $11.1 Million
Q1 2019

May 14, 2019
BUY
$9.96 - $13.44 $159,120 - $214,717
15,976 Added 1.76%
925,144 $11.5 Million
Q4 2018

Feb 13, 2019
BUY
$8.47 - $14.71 $1.55 Million - $2.7 Million
183,350 Added 25.26%
909,168 $8.61 Million
Q3 2018

Nov 08, 2018
BUY
$13.7 - $17.12 $1.55 Million - $1.93 Million
112,879 Added 18.42%
725,818 $10.5 Million
Q2 2018

Aug 13, 2018
BUY
$14.63 - $19.19 $1.53 Million - $2 Million
104,307 Added 20.51%
612,939 $9.89 Million
Q1 2018

May 14, 2018
SELL
$16.06 - $25.35 $37,612 - $59,369
-2,342 Reduced 0.46%
508,632 $8.26 Million
Q4 2017

Feb 13, 2018
BUY
$10.51 - $17.22 $5.37 Million - $8.8 Million
510,974
510,974 $8.58 Million

Others Institutions Holding GLYC

# of Institutions
35
Shares Held
17.8M
Call Options Held
0
Put Options Held
0
View Full List

About GLYCOMIMETICS INC

GLYC Quotes by TradingView
  • Ticker GLYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,423,900
  • Market Cap $16.8M
  • Description
  • GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...
More about GLYC
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email